EkblomBHaggstromJE. Clozapine (Leponex) compared with chlorpromazine: A
double-blind evaluation of pharmacological and clinical
properties. Curr Ther Res1974; 16:
945–57.
2.
Van PraggHMKorfJDolsLCW. Clozapine versus perphenazine: The value of the
biochemical mode of action of neuroleptics in predicting their therapeutic
activity. Br J Psychiatry1976; 129:
547–55.
3.
ChiuEBurrowsGStevensonJ. Double-blind comparison of clozapine with
chlorpromazine in acute schizophrenic illness. Aust NZ J
Psychiatry1976; 10:
343–7.
4.
Fischer-CornelssenKFernerU. An example of European multi-center trials:
Multispectral analysis of clozapine. Psychopharmacol
Bull1976; 12:
34–9.
5.
GuirguisEVoineskosGGrayJSchliemanE. Clozapine (Leponex) versus chlorpromazine (Largactil)
in acute schizophrenia (a double-blind controlled study).
Curr Ther Res1977; 21:
707–19.
6.
GelenbergADollerJ. Clozapine versus chlorpromazine for the treatment of
schizophrenia: Preliminary results from a double-blind study.
J Clin Psychiatry1979; 40:
238–40.
7.
LeonCAEstradaH. Efectos terapeuticos de la clozapine sobre los
sintomas de psicosis. Rev Colomb Psiquiatr1974; 3:
309–18.
8.
ShopsinBKleinHAaronsomMColloraM. Clozapine, chlorpromazine, and placebo in newly
hospitalized, acutely schizophrenic patients. Arch Gen
Psychiatry1979; 36:
657–64.
ClaghornJHonigfeldGAbuzzahabFThe risks and benefits of clozapine versus
chlorpromazine. J Clin Psychopharmacol1987; 7:
377–84.
11.
KaneJHongifeldGSingerJClozapine for the treatment-resistant schizophrenic.
Arch Gen Psychiatry1988; 45:
789–96.
12.
SchmutzJEichenbergerE. Clozapine. Chron Drug
Discov1982; 1:
39–59.
13.
AydFJ. Clozapine: A unique new neuroleptic.
Int Drug Ther Newsl1974; 9:
5–12.
14.
AndenNEStockG. Effect of clozapine on the turnover of dopamine in
the corpus striatum and in the limbic system. J Pharm
Pharmacol1973; 25:
346–8.
15.
CreeseILeffSE. Dopamine receptors: A classification.
J Clin Psychopharmacol1982; 2:
329–35.
16.
FardeLFritz-AxelWHalldinCSedvallG. Central D2-dopamine receptor occupancy in
schizophrenic patients treated with antipsychotic drugs.
Arch Gen Psychiatry1988; 45:
71–6.
17.
ChocMGLehrRGHsuanFMultiple-dose pharmacokinetics of clozapine in
patients. Pharm Res1987; 4:
402–5.
18.
ChengYFLundbergTBondessonULindstromLGabrielssonJ. Clinical pharmacokinetics of clozapine in chronic
schizophrenic patients. Eur J Clin Pharmacol1988; 34;
445–9.
19.
EreshefskyLCrismonMLSakladSR. Intraindividual pharmacokinetic assessment of
clozapine (abstract). Pharmacotherapy1988; 8: 137.
20.
Balant-GorgiaAEBalantL. Antipsychotic drugs: Clinical pharmacokinetics of
potential candidates for plasma concentration monitoring.
Clin Pharmacokinet1987; 13:
65–90.
21.
BablenisEWeberSSWagnerRL. Clozapine: A novel antipsychotic
agent. Drug Intell Clin Pharm1989; 23:
109–15.
22.
SayersACAmslerHA. Clozapine. Pharmacol Biochem
Prop Drug Substit1977; 1:
1–31.
23.
LeonCA. Therapeutic effects of clozapine: A four year
follow-up of a controlled clinical trial. Acta Psychiatr
Scand1979; 59:
471–80.
24.
PovlsenU JuulNoringUFogRTolerability and therapeutic effect of clozapine: A retrospective
investigation of 216 patients treated with clozapine for up to 12
years. Acta Psychiatr Scand1985; 71:
176–85.
25.
AmslerHATeerenhoviLBarthEHarjulaKVuopioP. Agranulocytosis in patients treated with
clozapine. Acta Psychiatr Scand1977; 56:
241–8.
26.
SmallJGMilsteinVMarhenkeJDHallDKellamsJ. Treatment outcome with clozapine in tardive
dyskinesia, neuroleptic sensitivity, and treatment-resistant
psychosis. J Clin Psychiatry1987; 48:
263–7.
27.
GerbinoLShopsinBColloraM. Clozapine in the treatment of tardive dyskinesia: An
interim report. In: FannWESmithRCDavisJMDominoEF, eds. Tardive dyskinesia: Research and treatments.
New York:
Spectrum, 1980;
475–89.
28.
ShopsinBKleinHAaronsomM. Clozapine: Double-blind controlled trial in the
treatment of acute schizophrenia. Psychopharmacol
Bull1978; 4:
12–5.
29.
LiebermanJAJohnsCAKaneJMClozapine-induced agranulocytosis: Noncross-reactivity with other
psychotropic drugs. J Clin Psychiatry1988; 49:
271–7.
30.
EkblomBErikssonKLindstromLH. Supersensitivity psychosis in schizophrenic patients
after sudden clozapine withdrawal.
Psychopharmacology1984; 83:
293–4.
31.
PerenyiAKunczEBagdyG. Early relapse after sudden withdrawal or dose
reduction of clozapine (letter).
Psychopharmacology1985; 86: 244.
32.
EklundK. Supersensitivity and clozapine withdrawal
(letter). Psychopharmacology1987; 91: 135.
